Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
Release: Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma in the Ovarian and Breast Cancer Spaces
Fri, 03/2/18 - 09:42 am
Skyline Medical
Helomics
GLG Pharma
ovarian cancer
breast cancer
ascites
Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents
CNBC
Tue, 02/6/18 - 11:47 am
JNJ
ovarian cancer
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
Sat, 01/20/18 - 02:56 pm
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
PharmaMar stock tanks after PhIII ovarian cancer study flops
Endpoints
Sat, 01/20/18 - 02:53 pm
PharmaMar
ovarian cancer
clinical trials
Zepsyre
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
3 Companies Competing to Gain Lead in Ovarian Cancer Market
Yahoo/Zacks.com
Sat, 11/25/17 - 12:35 pm
ovarian cancer
AstraZeneca
Merck
Lynparza
Rubraca
Clovis Oncology
Zejula
Tesaro
AstraZeneca, Merck, Clovis and Tesaro, all vying for share, may all win on faster PARP growth
Fierce Pharma
Wed, 11/15/17 - 08:51 pm
AstraZeneca
Merck
Clovis Oncology
Tesaro
PARP inhibitors
ovarian cancer
Zejula
Rubraca
Lynparza
AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
Fierce Pharma
Mon, 10/2/17 - 10:10 pm
AstraZeneca
Tesaro
Clovis Oncology
PARP inhibitors
drug pricing
ovarian cancer
Lynparza
Zejula
Rubraca
ESMO17: Clovis seeking new indication on positive ARIEL3 data
BioPharma Dive
Sun, 09/10/17 - 11:32 am
ESMO
Clovis Oncology
Rubraca
ovarian cancer
J&J Investors Should Ignore The Noise Of Cancer Lawsuits For Now
Seeking Alpha
Mon, 08/28/17 - 10:27 pm
JNJ
ovarian cancer
Here's Why Clovis Stock Is Up Almost 60% So Far in 2017
Yahoo/Zacks.com
Thu, 08/24/17 - 09:49 am
Clovis Oncology
Rubraca
ovarian cancer
Ovarian Cancer Market Still Up For Grabs
Barron's
Sat, 08/19/17 - 10:48 am
ovarian cancer
Lynparza
Tesaro
AstraZeneca
Clovis Oncology
Can Pfizer Bank on New Immunotherapy Bavencio for Growth?
Yahoo/Zacks.com
Fri, 08/18/17 - 12:01 am
Pfizer
Bavencio
immuno-oncology
renal cell carcinoma
lung cancer
ovarian cancer
head and neck cancer
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
Thu, 07/13/17 - 09:03 am
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
AstraZeneca Is Focused on Lynparza’s Label Expansion in 2017
Market Realist
Mon, 07/10/17 - 11:39 am
AstraZenca
Lynparza
BRCA-mutated ovarian cancer
ovarian cancer
Here's Why Clovis Oncology Inc. Jumped 70% in June
Motley Fool
Fri, 07/7/17 - 08:33 am
Clovis Oncology
ovarian cancer
Rubraca
AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US
Yahoo
Wed, 03/29/17 - 09:05 am
AstraZeneca
Lynparza
olaparib
ovarian cancer
Tesaro's PARP inhibitor approved in ovarian cancer
BioPharma Dive
Mon, 03/27/17 - 10:38 pm
Tesaro
ovarian cancer
PARP inhibitors
niraparib
AZ gears up for FDA filing as PARP inhibitor Lynparza wins big in ovarian cancer trial
Fierce Pharma
Tue, 03/14/17 - 04:43 pm
AstraZeneca
PARP inhibitors
Lynparza
FDA
ovarian cancer
clinical trials
Tesaro sees a $5B market opportunity for its cancer drug
Bizjournals.com
Fri, 02/17/17 - 10:14 am
Tesaro
niraparib
ovarian cancer
breast cancer
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »